Effect of AZD4017, a Selective 11β-HSD1 Inhibitor, on Bone Turnover Markers in Postmenopausal OsteopeniaAfroze Abbas, Paul M. Stewart, Gemma Ainsworth et al.|The Journal of Clinical Endocrinology & Metabolism|2022Cited by 11